172 related articles for article (PubMed ID: 22170300)
1. A novel risperidone-loaded SAIB-PLGA mixture matrix depot with a reduced burst release: effects of solvents and PLGA on drug release behaviors in vitro/in vivo.
Lin X; Yang S; Gou J; Zhao M; Zhang Y; Qi N; He H; Cai C; Tang X; Guo P
J Mater Sci Mater Med; 2012 Feb; 23(2):443-55. PubMed ID: 22170300
[TBL] [Abstract][Full Text] [Related]
2. [Preparation and evaluation of risperidone-loaded microsphere/sucrose acetate isobutyrate in situ forming complex depot with double diffusion barriers].
Lin X; Tang X; Xu YH; Zhang Y; Zhang Y; He HB
Yao Xue Xue Bao; 2015 Jun; 50(6):775-82. PubMed ID: 26521452
[TBL] [Abstract][Full Text] [Related]
3. Tracking the effect of microspheres size on the drug release from a microsphere/sucrose acetate isobutyrate (SAIB) hybrid depot in vitro and in vivo.
Lin X; Wang J; Xu Y; Tang X; Chen J; Zhang Y; Zhang Y; Yang Z
Drug Dev Ind Pharm; 2016 Sep; 42(9):1455-65. PubMed ID: 26790718
[TBL] [Abstract][Full Text] [Related]
4. Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release.
Lu Y; Yu Y; Tang X
J Pharm Sci; 2007 Dec; 96(12):3252-62. PubMed ID: 17721936
[TBL] [Abstract][Full Text] [Related]
5. Sustained release of risperidone from biodegradable microspheres prepared by in-situ suspension-evaporation process.
An T; Choi J; Kim A; Lee JH; Nam Y; Park J; Sun Bk; Suh H; Kim CJ; Hwang SJ
Int J Pharm; 2016 Apr; 503(1-2):8-15. PubMed ID: 26899975
[TBL] [Abstract][Full Text] [Related]
6. Microparticles produced by the hydrogel template method for sustained drug delivery.
Lu Y; Sturek M; Park K
Int J Pharm; 2014 Jan; 461(1-2):258-69. PubMed ID: 24333903
[TBL] [Abstract][Full Text] [Related]
7. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.
Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y
Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277
[TBL] [Abstract][Full Text] [Related]
8. A Uniform Ultra-Small Microsphere/SAIB Hybrid Depot with Low Burst Release for Long-Term Continuous Drug Release.
Lin X; Xu Y; Tang X; Zhang Y; Chen J; Zhang Y; He H; Yang Z
Pharm Res; 2015 Nov; 32(11):3708-21. PubMed ID: 26077999
[TBL] [Abstract][Full Text] [Related]
9. Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implants.
Desai KG; Mallery SR; Schwendeman SP
Eur J Pharm Biopharm; 2008 Sep; 70(1):187-98. PubMed ID: 18472254
[TBL] [Abstract][Full Text] [Related]
10. An Accelerated Release Method of Risperidone Loaded PLGA Microspheres with Good IVIVC.
Hu X; Zhang J; Tang X; Li M; Ma S; Liu C; Gao Y; Zhang Y; Liu Y; Yu F; Yang Y; Guo J; Li Z; Mei X
Curr Drug Deliv; 2018; 15(1):87-96. PubMed ID: 28521697
[TBL] [Abstract][Full Text] [Related]
11. Microsphere delivery of Risperidone as an alternative to combination therapy.
D'Souza S; Faraj J; DeLuca P
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
[TBL] [Abstract][Full Text] [Related]
12. Delivery of radix ophiopogonis polysaccharide via sucrose acetateisobutyrate-based in situ forming systems alone or combined with itsmono-PEGylation.
Wang L; Zheng X; Wu F; Shen L; Lin X; Feng Y
Drug Deliv; 2018 Nov; 25(1):267-277. PubMed ID: 29334805
[TBL] [Abstract][Full Text] [Related]
13. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
Desai KG; Mallery SR; Schwendeman SP
Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
[TBL] [Abstract][Full Text] [Related]
14. Effect of bases with different solubility on the release behavior of risperidone loaded PLGA microspheres.
Hu Z; Liu Y; Yuan W; Wu F; Su J; Jin T
Colloids Surf B Biointerfaces; 2011 Aug; 86(1):206-11. PubMed ID: 21524893
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation.
Su ZX; Shi YN; Teng LS; Li X; Wang LX; Meng QF; Teng LR; Li YX
Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594
[TBL] [Abstract][Full Text] [Related]
16. Accelerated polymer biodegradation of risperidone poly(D, L-lactide-co-glycolide) microspheres.
Selmin F; Blasi P; DeLuca PP
AAPS PharmSciTech; 2012 Dec; 13(4):1465-72. PubMed ID: 23090111
[TBL] [Abstract][Full Text] [Related]
17. In vivo evaluation of risperidone-SAIB in situ system as a sustained release delivery system in rats.
Lu Y; Tang X; Cui Y; Zhang Y; Qin F; Lu X
Eur J Pharm Biopharm; 2008 Feb; 68(2):422-9. PubMed ID: 17614267
[TBL] [Abstract][Full Text] [Related]
18. Long-Lasting
Bazraee S; Mobedi H; Mashak A; Jamshidi A
Curr Drug Deliv; 2022; 19(1):157-166. PubMed ID: 34139983
[TBL] [Abstract][Full Text] [Related]
19. Analysis of initial burst in PLGA microparticles.
Allison SD
Expert Opin Drug Deliv; 2008 Jun; 5(6):615-28. PubMed ID: 18532918
[TBL] [Abstract][Full Text] [Related]
20. Beyond Q1/Q2: The Impact of Manufacturing Conditions and Test Methods on Drug Release From PLGA-Based Microparticle Depot Formulations.
Garner J; Skidmore S; Park H; Park K; Choi S; Wang Y
J Pharm Sci; 2018 Jan; 107(1):353-361. PubMed ID: 29107048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
